WSC 2023 | Extracranial vertebral artery stenosis: subgroups who can benefit from stent placement

Extracranial vertebral artery stenosis (EVAS) is a significant predictor for ischemic stroke resulting in high rates of death and disability. Adnan Qureshi, MD, University of Missouri-Columbia, Columbia, MO, identifies subgroups of EVAS patients who show the greatest benefit from stent placement, a relatively low-risk but invasive procedure to reduce the risk of recurrent ischemic stroke. Dr Qureshi’s study found that patients with stroke as a qualifying event and those treated within 30 days of ischemic event benefited the most from stent placement. These findings should be used to inform patient selection for future wide-scale clinical trials, with aim to implement findings into healthcare systems. This interview took place at the World Stroke Congress (WSC) 2023 in Toronto, Canada.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.